BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 2677298)

  • 1. Phagocytosis of Cryptococcus neoformans by rat alveolar macrophages.
    Bolaños B; Mitchell TG
    J Med Vet Mycol; 1989; 27(4):203-17. PubMed ID: 2677298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Killing of Cryptococcus neoformans by rat alveolar macrophages.
    Bolaños B; Mitchell TG
    J Med Vet Mycol; 1989; 27(4):219-28. PubMed ID: 2677299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phagocytosis and killing of Cryptococcus neoformans by rat alveolar macrophages in the absence of serum.
    Bolaños B; Mitchell TG
    J Leukoc Biol; 1989 Dec; 46(6):521-8. PubMed ID: 2681492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of interleukin-6 mRNA in rat alveolar macrophages by in vitro exposure to both Cryptococcus neoformans and anti-C. neoformans antiserum.
    Li RK; Mitchell TG
    J Med Vet Mycol; 1997; 35(5):327-34. PubMed ID: 9402525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of granulocyte-macrophage colony-stimulating factor on rat alveolar macrophage anticryptococcal activity in vitro.
    Chen GH; Curtis JL; Mody CH; Christensen PJ; Armstrong LR; Toews GB
    J Immunol; 1994 Jan; 152(2):724-34. PubMed ID: 8283047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paradoxical role of capsule in murine bronchoalveolar macrophage-mediated killing of Cryptococcus neoformans.
    Levitz SM; DiBenedetto DJ
    J Immunol; 1989 Jan; 142(2):659-65. PubMed ID: 2521352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between Cryptococcus neoformans and alveolar macrophages.
    Gross NT; Nessa K; Camner P; Chinchilla M; Jarstrand C
    J Med Vet Mycol; 1997; 35(4):263-9. PubMed ID: 9292423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The capsule of cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages.
    Kozel TR; Gotschlich EC
    J Immunol; 1982 Oct; 129(4):1675-80. PubMed ID: 7050244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth inhibition of Cryptococcus neoformans by human alveolar macrophages.
    Weinberg PB; Becker S; Granger DL; Koren HS
    Am Rev Respir Dis; 1987 Nov; 136(5):1242-7. PubMed ID: 3314617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies can affect complement deposition on the capsule of the pathogenic fungus Cryptococcus neoformans by both classical pathway activation and steric hindrance.
    Zaragoza O; Casadevall A
    Cell Microbiol; 2006 Dec; 8(12):1862-76. PubMed ID: 16824038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fungicidal activity of IFN-gamma-activated macrophages. Extracellular killing of Cryptococcus neoformans.
    Flesch IE; Schwamberger G; Kaufmann SH
    J Immunol; 1989 May; 142(9):3219-24. PubMed ID: 2496162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage-mediated fungistasis in vitro: requirements for intracellular and extracellular cytotoxicity.
    Granger DL; Perfect JR; Durack DT
    J Immunol; 1986 Jan; 136(2):672-80. PubMed ID: 3510251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An ultrastructural examination of the interaction between macrophages and Cryptococcus neoformans.
    Papadimitriou JM; Robertson TA; Kletter Y; Aronson M; Walters MN
    J Pathol; 1978 Feb; 124(2):103-9. PubMed ID: 363987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of Cryptococcus neoformans by human cultured macrophages. Requirements for multiple complement receptors and actin.
    Levitz SM; Tabuni A
    J Clin Invest; 1991 Feb; 87(2):528-35. PubMed ID: 1991837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opsonization of Cryptococcus neoformans by human immunoglobulin G: role of immunoglobulin G in phagocytosis by macrophages.
    Kozel TR; McGaw TG
    Infect Immun; 1979 Jul; 25(1):255-61. PubMed ID: 383614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization on encapsulated Cryptococcus neoformans of serum components opsonic for phagocytosis by macrophages and neutrophils.
    Kozel TR; Highison B; Stratton CJ
    Infect Immun; 1984 Feb; 43(2):574-9. PubMed ID: 6363293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trypanosoma lewisi-induced immunosuppression: the effects on alveolar macrophage activities against Cryptococcus neoformans.
    Gross NT; Guerrero OM; Chinchilla M; Jarstrand-Hall C
    Exp Parasitol; 2006 Aug; 113(4):262-6. PubMed ID: 16546172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the capsule in phagocytosis of Cryptococcus neoformans.
    Kozel TR; Pfrommer GS; Guerlain AS; Highison BA; Highison GJ
    Rev Infect Dis; 1988; 10 Suppl 2():S436-9. PubMed ID: 3055212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of nitric oxide by rat alveolar macrophages stimulated by Cryptococcus neoformans or Aspergillus fumigatus.
    Gross NT; Nessa K; Camner P; Jarstrand C
    Med Mycol; 1999 Jun; 37(3):151-7. PubMed ID: 10421846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C1q enhances the phagocytosis of Cryptococcus neoformans blastospores by human monocytes.
    Bobak DA; Washburn RG; Frank MM
    J Immunol; 1988 Jul; 141(2):592-7. PubMed ID: 3290342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.